Zoetis Inc. (ETR:ZOE)
Germany
· Delayed Price · Currency is EUR | Market Cap | 68.75B |
| Revenue (ttm) | 8.94B |
| Net Income (ttm) | 2.40B |
| Shares Out | n/a |
| EPS (ttm) | 5.28 |
| PE Ratio | 28.63 |
| Forward PE | n/a |
| Dividend | 1.68 (1.10%) |
| Ex-Dividend Date | Apr 21, 2025 |
| Volume | 734 |
| Average Volume | 259 |
| Open | 151.18 |
| Previous Close | 150.58 |
| Day's Range | 150.50 - 153.00 |
| 52-Week Range | 136.70 - 185.00 |
| Beta | 0.90 |
| RSI | 39.34 |
| Earnings Date | Feb 14, 2025 |
About Zoetis
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other ph... [Read more]
Financial Performance
In 2024, Zoetis's revenue was $9.26 billion, an increase of 8.33% compared to the previous year's $8.54 billion. Earnings were $2.49 billion, an increase of 6.06%.
Financial numbers in USD Financial StatementsNews
Zoetis to Participate in Upcoming Investor Conferences
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) today announced that a representative from the company will participate in the following investor conferences. Bank of ...
Zoetis CEO on bird flu vaccine
Zoetis received a conditional license for its bird flu vaccine from the US Department of Agriculture to help fight the spread of the disease on poultry farms. Here's what CEO Kristin Peck had to say
Zoetis Avian Influenza Vaccine Secures Conditional Approval In US For Use In Chickens
On Friday, the U.S. Department of Agriculture (USDA) Center for Veterinary Biologics (CVB) issued Zoetis Inc (NYSE: ZTS) a conditional license for its Avian Influenza Vaccine, H5N2 Subtype, Killed Vi...
If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today
Zoetis (NYSE: ZTS) has outperformed the market over the past 10 years by 2.1% on an annualized basis producing an average annual return of 13.25%. Currently, Zoetis has a market capitalization of $71...
Zoetis (ZTS) Stock Dips Due to Analyst Price Target Cuts
Zoetis (ZTS) Stock Dips Due to Analyst Price Target Cuts
Why Zoetis Stock Took Another Tumble Today
Zoetis Inc (ZTS) Secures Conditional License for Avian Influenza Vaccine
Zoetis Inc (ZTS) Secures Conditional License for Avian Influenza Vaccine
Zoetis gains conditional license for avian flu vaccine in chickens
US grants conditional clearance to Zoetis' bird flu vaccine for poultry
Zoetis said on Friday its bird flu vaccine has received the U.S. Department of Agriculture's conditional license for use in poultry.
Zoetis Receives Conditional License from USDA for Avian Influenza Vaccine, H5N2 Subtype, Killed Virus
Zoetis today announced that the U.S. Department of Agriculture (USDA), Center for Veterinary Biologics (CVB) has issued the company a conditional license for its Avian Influenza Vaccine, H5N2 Subtype,...
Zoetis Receives Conditional License from USDA for Avian Influenza Vaccine, H5N2 Subtype, Killed Virus
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #HPAI--Zoetis today announced that the U.S. Department of Agriculture (USDA), Center for Veterinary Biologics (CVB) has issued the company a conditional lice...
Zoetis CEO says Avian Flu vaccine for poultry gets USDA approval
Zoetis CEO Kristin Peck joins 'Closing Bell Overtime' to talk its Avian Flu vaccine, the impact of tariffs, and more.
Zoetis CEO says Avian Flu vaccine for poultry gets USDA approval
Zoetis CEO Kristin Peck joins 'Closing Bell Overtime' to talk its Avian Flu vaccine, the impact of tariffs, and more.
Zoetis: In-Line Q4 Earnings And Weak Guidance Present A Buying Opportunity
Zoetis Inc. (ZTS) Q4 2024 Earnings Call Transcript
Why Zoetis Stock Was Falling Today
Zoetis (ZTS) Q4 2024 Earnings Call Transcript
ZTS earnings call for the period ending December 31, 2024.
Zoetis Earnings Top Analysts' Forecasts
Zoetis exceeded market expectations in Q4 2024, with impressive financial performance despite challenges in specific segments.
Zoetis Drops As 2025 Guidance Falls Short Of Estimates
On Thursday, Zoetis Inc (NYSE: ZTS) reported a fourth-quarter 2024 adjusted EPS of $1.40, up from $1.24 a year ago, beating the consensus of $1.34 . Adjusted net income for the fourth quarter of 2024...
Zoetis Drops As 2025 Guidance Falls Short Of Estimates
On Thursday, Zoetis Inc ZTS reported a fourth-quarter 2024 adjusted EPS of $1.40, up from $1.24 a year ago, beating the consensus of $1.34.
Zoetis Inc. 2024 Q4 - Results - Earnings Call Presentation
Zoetis falls 7% on soft 2025 guidance
Zoetis shares drop 7% premarket as 2025 revenue and earnings guidance fall below consensus. Read more here.
Zoetis Plunges 9% As 2025 Guidance Misses Expectations
Zoetis stock plunged Thursday after the company's 2025 guidance missed forecasts, though fourth-quarter metrics beat.
Zoetis forecasts 2025 profit, revenue below estimates; shares fall
Animal healthcare company Zoetis forecast annual profit and revenue below Wall Street estimates on Thursday, partly due to a hit from a stronger dollar, sending its shares down 9% in premarket trading...